Translational Development Acquisition net income falls to $1.33 million in Q1 FY26

Translational Development Acquisition Corp.

Translational Development Acquisition Corp.

TDAC

0.00
  • Translational Development Acquisition posted net income of USD 1.33 million for the three months ended March 31, 2026, down 10.13% from a year earlier.
  • Dividends on marketable securities held in the trust account fell to USD 1.61 million, while general and administrative costs declined to USD 281,161.
  • Marketable securities in the trust account totaled USD 183.27 million at March 31, 2026, with no interest withdrawn through quarter-end.
  • Cash outside the trust account was USD 24,630, with USD 500,000 borrowed under a non-interest-bearing promissory note due at closing of a business combination.
  • Management said it has until June 24, 2026 to consummate an initial business combination, and flagged substantial doubt about going-concern ability if it fails to close by that deadline.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Translational Development Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-061556), on May 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.